Telehealth
The Centers for Disease Control and Prevention released guidance on using telehealth to expand access to health care services during the COVID-19 pandemic and beyond.
This edition of Hacking Healthcare includes an update on the progress various countries are making on digital contact-tracing and outlines the important role healthcare organizations play in advancing discussion on the topic.
If you’re wondering how significant the long-term impact of the soaring use of telehealth services during the COVID-19 pandemic could be on health care, a new analysis from McKinsey & Co. pegs the number at $250 billion.
The pandemic’s impact on how consumers access health care is being measured on a daily basis, and early data show dramatic increases in virtual care visits. Now, researchers and provider organizations are assessing how consumers’ experiences during the pandemic may affect how they access care in…
AHA letter to Rep. Eshoo expressing support of the Health Care Broadband Expansion During COVID-19 Act, which proposes improvements to the Federal Communications Commission (FCC) Rural Health Care Program.
AHA Expresses Support for the Health Care Broadband Expansion During COVID-19 Act, which proposes improvements to the Federal Communications Commission (FCC) Rural Health Care Program.
The AHA responded to a Centers for Medicare & Medicaid Services request for information by offering solutions for improving maternal and child health in rural communities.
AHA urged the Federal Communications Commission to grant expedited approval to its request that the agency extend the COVID-19 Telehealth Program to all hospitals and other direct patient care facilities, regardless of their size, location, or for-profit or not-for-profit status.
Dear Chairman Pai:
A panel of 4 experts discussed federal policy emerging from Congress and the Administration under COVID-19 focusing on rural health priorities and took questions from the audience. They reviewed emergency funding, Medicare and Medicaid payment improvements, telehealth, regulatory relief, 340B drug…